ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Halberd Corp (PK)

Halberd Corp (PK) (HALB)

0.0018
-0.0007
(-28.00%)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
0.0018
Bid
0.0018
Ask
0.0025
Volume
398,000
0.0018 Day's Range 0.0023
0.0014 52 Week Range 0.01
Market Cap
Previous Close
0.0025
Open
0.0023
Last Trade
29000
@
0.0018
Last Trade Time
Financial Volume
$ 806
VWAP
0.002025
Average Volume (3m)
640,317
Shares Outstanding
635,880,000
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-0
Revenue
1,000
Net Profit
-80k

About Halberd Corp (PK)

Halberd Corp is a research-based company seeking to develop treatments for a range of diseases. Their extracorporeal method treats blood-borne, neurologic and infectious diseases. Halberd's patents remove bodily fluids in a continuous fashion, like dialysis, or in a batch process. To treat the speci... Halberd Corp is a research-based company seeking to develop treatments for a range of diseases. Their extracorporeal method treats blood-borne, neurologic and infectious diseases. Halberd's patents remove bodily fluids in a continuous fashion, like dialysis, or in a batch process. To treat the specific disease, the treatment is applied to the bodily fluid. Disease eradication via exposure to radio frequency, laser irradiation, or chemical bonding. The cleansed bodily fluids are then returned to the patient without deadly side effects found with injected or ingested medications. Halberds technology base is 4 issued patents and 22 pending patents: Current projects with planned submissions of abstracts to ARPA-H include: * Extracorporeal eradication of inflammatory cytokines from cerebrospinal fluid associated with PTSD and Suicidal Ideation * Therapeutic lozenges to alleviate pain and anxiety as well as chemical and alcohol addiction * Eradication of antibiotic-resistant bacteria and deadly Candida Auris fungi supplied by CDC * Development of a nasal spray is in pre-clinical testing designed to eliminate neurodegenerative cascade associated of head trauma * Extracorporeal eradication of antigens associated with cancer * Extracorporeal eradication of the 10 inflammatory cytokines & the excitatory neurotransmitter associated with Alzheimer's Disease, Parkinson's Disease & Epilepsy * Development of antibodies against Coronavirus & extracorporeal eradication of Covid antigens. Show more

Sector
Medical Laboratories
Industry
Medical Laboratories
Headquarters
Huntington Woods, Michigan, USA
Founded
-
Halberd Corp (PK) is listed in the Medical Laboratories sector of the OTCMarkets with ticker HALB. The last closing price for Halberd (PK) was $0. Over the last year, Halberd (PK) shares have traded in a share price range of $ 0.0014 to $ 0.01.

Halberd (PK) currently has 635,880,000 shares outstanding. The market capitalization of Halberd (PK) is $1.59 million. Halberd (PK) has a price to earnings ratio (PE ratio) of 0.00.

HALB Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0004-18.18181818180.00220.00250.00184635710.00247882CS
4-0.00044-19.64285714290.002240.00280.001410875190.00244349CS
12-0.0007-280.00250.00280.00146403170.00229214CS
26-0.0013-41.9354838710.00310.00450.00148380200.00273212CS
52-0.00575-76.15894039740.007550.010.00148251820.00410722CS
156-0.0135-88.23529411760.01530.01960.001411200020.00850104CS
260-0.004-68.96551724140.00580.1090.001440254010.03121355CS

HALB - Frequently Asked Questions (FAQ)

What is the current Halberd (PK) share price?
The current share price of Halberd (PK) is $ 0.0018
How many Halberd (PK) shares are in issue?
Halberd (PK) has 635,880,000 shares in issue
What is the market cap of Halberd (PK)?
The market capitalisation of Halberd (PK) is USD 1.59M
What is the 1 year trading range for Halberd (PK) share price?
Halberd (PK) has traded in the range of $ 0.0014 to $ 0.01 during the past year
What is the reporting currency for Halberd (PK)?
Halberd (PK) reports financial results in USD
What is the latest annual turnover for Halberd (PK)?
The latest annual turnover of Halberd (PK) is USD 1,000
What is the latest annual profit for Halberd (PK)?
The latest annual profit of Halberd (PK) is USD -80k
What is the registered address of Halberd (PK)?
The registered address for Halberd (PK) is 10755 VERNON AVENUE, HUNTINGTON WOODS, MICHIGAN, 48070
Which industry sector does Halberd (PK) operate in?
Halberd (PK) operates in the MEDICAL LABORATORIES sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RGFCReal Good Food Company Inc (CE)
$ 0.075
(74,900.00%)
517
SDCCQSmileDirectClub Inc (CE)
$ 0.0002
(19,900.00%)
117.55k
PROCFProcaps Group SA (CE)
$ 1.45
(14,256.44%)
100
AAPJAAP Inc (CE)
$ 0.0001
(9,900.00%)
1M
ZPTAZapata Computing Holdings Inc (CE)
$ 0.0001
(9,900.00%)
1.63k
ANDRAndrea Electronics Corporation (CE)
$ 0.000001
(-99.67%)
100
ANGCFEon Lithium Corporation (PK)
$ 0.0036
(-99.64%)
210
CRTLCartel Blue Inc (CE)
$ 0.0002
(-99.60%)
902
KLGGKlegg Electronics Inc (CE)
$ 0.000001
(-99.00%)
10.56k
VAXXVaxxinity Inc (CE)
$ 0.0001
(-99.00%)
10.95k
GTCHGBT Technologies Inc (PK)
$ 0.0003
(-11.76%)
723.24M
CYBLCyberlux Corp New (PK)
$ 0.0129
(50.00%)
353.76M
TONRTonner One World Holdings Inc (PK)
$ 0.0003
(50.00%)
298.57M
PSWWPrincipal Solar Inc (PK)
$ 0.0004
(0.00%)
265.01M
HMBLHUMBL Inc (PK)
$ 0.00025
(-16.67%)
262.04M

HALB Discussion

View Posts
squidster squidster 2 days ago
Current judgments payable $3,062,182
315,688,866 shares to be issued based on judgement.
$150,000 SBA loan they've defaulted on.
https://www.otcmarkets.com/file/company/financial-report/474554/content
READ THE FINANCIALS
👍️0
work-n-hard work-n-hard 3 days ago
Well, you know the money is getting tight, when you have to give up your P.O. Box as your The principal office mailing address and just have the mail sent to the CEO's home office.
(As per the latest filing in Co.)
👍️0
squidster squidster 3 days ago
Latest quarterly out, can't hide from the financials. No money, no products, no revenue, no employees, no relationship with ASU, Youngstown or MSU. Not enough O/S to payoff outstanding judgements...
https://www.otcmarkets.com/file/company/financial-report/474554/content
🤣 1
Aero-man Aero-man 4 days ago
Halberd has some very promising medical products (for PTSD, mental illness, etc) that are in the trial stages currently. It take much time and funding to get through these trials. So, they're seeking funding from private and government sources. This all takes time.
👍️ 1
work-n-hard work-n-hard 1 week ago
I notice that this type activity happens quite a bit, when their filings have a page that looks like this:

👍️0
squidster squidster 1 week ago
Should get another quarterly report next day or two
👍️0
squidster squidster 1 week ago
Don't look now o/s went up 30 million...
👍️0
EHRjunkie EHRjunkie 2 weeks ago
Halberd Corp. (OTC PINK:HALB), is a publicly traded company on the OTC Market, and is in full compliance with OTC Market reporting requirements (OTCID)

Halberd holds the exclusive rights to 4 granted U.S. Patents: no. 9,216,386 / no. 8,758,287 / no. 11,186,629 / no. 8,865,733 and 22 pending provisional patents

Halberd Corporation is a biotechnology research company and with its partners (Dr. Qiang Shawn Chen and his team at Arizona State University; Dr. William Sturrus and his team at Youngstown State University; Dr. Richard Carr and his team at Mississippi State University), is developing multiple treatments against PTSD, CTE, Alzheimer's Disease and other virusses and diseases:

Athena Telemedicine Partners LLC:
2024/2025: In close cooperation with partner (revenue sharing agreement in place) AthenaGTX, Halberd Corp is working on contracts from the military, to develop treatments to tackle Post Traumatic Stress Syndrome/PTSD and other diseases following head trauma. Key words are LDX and WatchDawg.

Mississippi State University:
2024/2025: Research Partner MSU is leading pre-clinical (animal) trials for Halberd's patent-pending nasal spray, called Tri-Ax. The three-component nasal spray mitigates the potential neurodegenerative cascade following head trauma. Animal tests at MSU with Halberd's nasal spray have achieved over 50% reduction in GlialFiblliary Acid Protein GFAP), the gold standard indicator of brain injury following head trauma. This product addresses an unmet need for use in the military, by first responders and contact sports teams.

Halberd Corp. and AthenaGTX filed several funding proposals for both treatments with multiple defense departments (ONR/US Army), but is also working on securing private funding
👍️ 5
retired early retired early 3 weeks ago
What better way to test and record patient progress with the studies as partnering with Athena Telemedicine Partners, LLC. :)
👍 1
work-n-hard work-n-hard 3 weeks ago
...and still, no matter how long the failure, nor how many shares are sold, those who have lost the most, must continue to push it forward.
It's their only hope.
JMO
👍️0
squidster squidster 3 weeks ago
Hartman in his early days:

https://bulmanwealth.com/investment-management/a-quick-history-of-the-snake-oil-salesman/
LMFAO
👍️0
Aero-man Aero-man 3 weeks ago
Good to see that things are still moving forward, but at a slow pace so far. Would be good to see a Development award soon from the military, to help with Halb's various medications that address a myriad of the people's health issues.
👍️0
retired early retired early 3 weeks ago
JACKSON CENTER, Pa., May 28, 2025 (GLOBE NEWSWIRE) -- Halberd Corporation (OTC: HALB) in cooperation with Athena Telemedicine Partners, LLC, announces astounding clinical efficacy for our patent-pending LDX compound for dialysis-borne neuropathy and pruritis in yet another case report and issues nationwide nephrologist solicitation for patients for a 100-patient study involving kidney disease.
👍️ 2
retired early retired early 4 weeks ago
The US Government Granted Athena GTX a $2,866,000 Final Development Contract Award!
👍️ 1
work-n-hard work-n-hard 1 month ago
Here's the guy: https://tenor.com/view/jimmy-durante-hachacha-gif-13131305
👎️ 1
squidster squidster 1 month ago
There's a reason the s/p is sitting at it's low since Hartman took over. It's got nothing to do with research of nasal spray at MSU...
👍️0
squidster squidster 1 month ago
Really, exaclty who from HALB is leading the nasal spray research at at MSU?

👍️0
retired early retired early 1 month ago
Got this from the C.E.O. earlier this year.
"The initial 10-person study was a resounding success. Data was transferred to the military. We are awaiting several potential contract awards as an impact of these initial successful results. The change of administration in Washington has obviously stalled any reaction. We are anxiously awaiting their reaction along with you."
I believe they will succeed this year or next. :)
👍 2
EHRjunkie EHRjunkie 2 months ago
Halberd is leading the Tri-Ax nasal spray project, jointly with Mississippi State University
👍️ 1
EHRjunkie EHRjunkie 2 months ago
AthenaGTX is leading the WatchDawg project, jointly in Athena Telemedicine Group
👍️ 1
EHRjunkie EHRjunkie 2 months ago
Partners in WatchDawg are AthenaGTX and Exalted Warriors Foundation
👍️ 1
EHRjunkie EHRjunkie 2 months ago
Working on WatchDawg to treat PTSD
👍️ 1
retired early retired early 2 months ago
It may look like nothing is happening but we will see it go to the moon when the 100 person trials end and support begins. can wait. :)
👍️0
work-n-hard work-n-hard 2 months ago
At one time, those 18's would have been sweet. But now, if you can't sell them for a profit....
And to make it worse, much of the OTC is paying nicely once again.
👎️ 1
squidster squidster 2 months ago
The ride is over: https://ih.advfn.com/stock-market/USOTC/halberd-pk-HALB/chart/streaming
👍️0
squidster squidster 3 months ago
HALB + BIEI + Hartman = R/S
👍️0
work-n-hard work-n-hard 3 months ago
He might need to evict the folks at BEBI and take that back over, once they can't sell anymore shares here?
Hartless Rides Again!
Just remembered, isn't this about the time of year that he and his daughter get their bonuses?
More shares inbound, if it hasn't happened already.
👎️ 1
squidster squidster 3 months ago
164 million share to dilute and then the R/S. Wash, rinse, repeat. Hartman's been doing it for 20 yrs...
👍️0
squidster squidster 3 months ago
$80.00 in volume...HALB has no products, no revenue, no employees so what kind of profit can they share?
What EXACTLY does "partnered with Athena GTX on a proft sharing agreement" mean?
The ride is over for Hartman...
👍️0
gkare gkare 3 months ago
"partnered with Athena GTX on a PROFIT SHARING agreement"
👍️ 1
work-n-hard work-n-hard 3 months ago
Summary: The other guys got some money, while WE are looking for financing. Bout sums it up.
More dilution coming.
👎️ 1
gkare gkare 3 months ago
Appears everyone missed this PR
👍️ 1
gkare gkare 3 months ago
https://halberdcorporation.com/progress-update-on-halberd-athena-gtx-and-athena-telemedicine-partnership-llc-joint-projects/
👍️ 2
work-n-hard work-n-hard 3 months ago
...and more shares to get there.
👍️0
squidster squidster 3 months ago
All the fluff in the last PR leads to this one sentance " This nasal spray technology product is believed to require a longer-term development process"
👍️ 1
retired early retired early 3 months ago
I have and results were very good. Increasing the pilot trials is underway. Very promising. "The initial 10-person study was a resounding success. Data was transferred to the military. We are awaiting several potential contract awards as an impact of these initial successful results. The change of administration in Washington has obviously stalled any reaction. We are anxiously awaiting their reaction along with you." :)
👍️0
squidster squidster 3 months ago
It wouldn't be good for those ducks if there's blood in the water. The saying is "it's time to buy when there's blood in the street"... Heard anything about those "research results" yet? SMFH
👍️0
Aero-man Aero-man 3 months ago
I think so. The ducks have been lined up and I believe it's just a matter of time until this thing starts to rock-n-roll!
👍️0
retired early retired early 4 months ago
Good move I believe. :)
👍️ 1
Aero-man Aero-man 4 months ago
Bought a nice load of cheap shares this week. Buying when there's "blood in the water".
👍️ 1
squidster squidster 4 months ago
That's some funny $shit right there.
Don't think I've seen HALB s/p this low before...
👍️0
work-n-hard work-n-hard 4 months ago
OTCN back on the Ask. Time to pay for the filings again.
👍️0
work-n-hard work-n-hard 4 months ago
New 52wk low. If you were ever going to risk some on a Stinky Pinky, this might a time to start looking.
👍️0
work-n-hard work-n-hard 4 months ago
Bet you didn't realize, just how much power we had. lol

https://www.barchart.com/stocks/quotes/HALB/interactive-chart

Or, is it that this is just a share selling show?
👍️0
squidster squidster 4 months ago
A 3 month old PR that talks about Athena's technology is not going to move the needle on this $hit show...
"Results from this sub-group should be available around mid-January"...
Heard anyting on those results? 😂
👎️ 1
Aero-man Aero-man 4 months ago
Halberd is still moving forward on this PTSD treatment that is much needed by the US military and the civilian population. Good things take time and do not just happen overnight, as some ignorantly believe.

Halberd Update on WatchDawg® PTSD Treatment

JACKSON CENTER, Pa., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Halberd Corporation (OTC PINK: HALB) previously reported results of a recently concluded initial 10-person Pilot Study of volunteer veterans suffering from PTSD and possible suicidal ideation. The results of that study can be found here. Based on the encouraging results of that initial pilot study, upgrades and enhancements to the data collection methodology, data analysis, hardware, software performance and reporting improvements have been incorporated into future studies. The next phase to be conducted on the patent-pending medicines/procedures is a 100-person study which will be conducted in sub-groups as volunteers are identified and qualified. The initial sub-group of 10 volunteers of this 100-person study have been selected. Results from this sub-group should be available around mid-January.
👍️0
Aero-man Aero-man 4 months ago
Halberd is still developing real medical products that address real medical issues, which takes much time and effort. Unfortunately, we have a few propaganda-schmendricks with nothing better to do than to spew their FUD trying to scare people away, thereby driving down the PPS. When it drops I buy more - just a matter of time before this pops back up.
👍️0
work-n-hard work-n-hard 4 months ago
Randall Goulding
1333 Sprucewood Ln
Deerfield IL 60015
US
👍️0
gkare gkare 4 months ago
That was a long time ago. Athena GTX is controlling this now.
👍️0
work-n-hard work-n-hard 4 months ago
When they first presented that address, a sat. view told the story for those of us too far away for the drive.
👍️0

Your Recent History

Delayed Upgrade Clock